Robert Pape

Vice President of Finance

Professional Overview
Robert Pape is an experienced finance executive with a strong track record in strategic financial planning, analysis, and operational leadership. As the Vice President of Finance at Immunitas Therapeutics, he oversees all aspects of the company's financial operations, driving data-driven decision-making and ensuring financial stability and growth.

Experience Summary

Current Role
As the Vice President of Finance at Immunitas Therapeutics, Robert is responsible for leading the company's financial strategy, budgeting, forecasting, and reporting processes. He collaborates closely with cross-functional teams to provide valuable financial insights that inform strategic business decisions and support the organization's ambitious growth targets. Under his leadership, the finance team has streamlined reporting systems, improved cash flow management, and optimized resource allocation to enable the company's rapid expansion.

Career Progression
Robert's finance career spans over a decade, during which he has steadily progressed through roles of increasing responsibility. Prior to joining Immunitas Therapeutics, he served as the Senior Director of Finance - FP&A at Keros Therapeutics, where he played a pivotal role in the company's successful initial public offering and subsequent capital raises. Earlier in his career, Robert held finance leadership positions at Organogenesis and NxStage Medical, contributing to the financial strategy and operational excellence of these fast-growing healthcare organizations.

Academic Background
Robert holds a Bachelor of Science in Finance from the University of Massachusetts Amherst, where he graduated with honors. He is a Certified Public Accountant (CPA) and has completed advanced training in financial modeling, capital markets, and strategic decision-making.

Areas of Expertise

• Financial planning and analysis

• Budgeting and forecasting

• Cash flow management and optimization

• Financial reporting and data-driven decision-making

• Strategic financial advisory and business partnering

• Financial system implementation and process improvement

• M&A integration and post-acquisition integration

Professional Impact
During his tenure at Keros Therapeutics, Robert played a pivotal role in the company's successful initial public offering, which raised over $150 million in capital. He also spearheaded the implementation of a new financial reporting system that enhanced transparency and decision-making capabilities across the organization. At Immunitas Therapeutics, Robert has overseen the integration of several strategic acquisitions, ensuring seamless financial operations and maximizing synergies.

Conclusion
With his deep expertise in financial management, strategic planning, and operational optimization, Robert Pape is a valuable asset to Immunitas Therapeutics. His proven ability to drive financial excellence and support the company's ambitious growth objectives positions him as a trusted strategic partner and leader within the organization.